BioSpace News Archive

Genetown

Cambridge Biotherapies Expands Innovative Services with Ketamine Infusions for Opioid-Free Pain Management

Cambridge Biotherapies proudly announces the launch of Ketamine Infusions for Pain and Headache Management, now available at all locations.

May 22, 2024
·
3 min read
Genetown

GENFIT: May 22, 2024 Combined Shareholders Meeting Results

GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, announced the results of the Combined Shareholders Meeting which took place on May 22, 2024.

May 22, 2024
·
4 min read
Business

Immunis Partners with Japanese Drug Company Toray to Reverse Sarcopenia

Immunis, Inc., a clinical-stage biotech developing innovative secretome therapies to address age-related disease and immune dysfunction, obtained a significant strategic milestone in partnering with Toray, a Japanese drug company part of the Toray Group.

May 22, 2024
·
3 min read
BioMidwest

Long Grove Pharmaceuticals Launches Premix Norepinephrine

It is a New Day for Norepinephrine! Long Grove Pharmaceuticals now offers ready-to-use Norepinephrine in 0.9% Sodium Chloride in the 16 mg/250mL (64 mcg/mL) strength and anticipates the availability of the 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL) strengths in early summer.

May 22, 2024
·
2 min read
Pharm Country

New Gene-Expression Patterns Linked to Schizophrenia, Bipolar Disorder and Major Depressive Disorder, New Study Shows

Psychiatric disorders like schizophrenia, bipolar disorder and depression have a strong genetic signature. Through advanced transcriptome-wide association studies, researchers can identify unique gene expression profiles to identify new drug targets to treat these disorders.

May 22, 2024
·
3 min read
Biotech Beach

Allez Health Announces $60 Million Capital Raise

Allez Health Inc., formerly known as Zense-Life Inc., an emerging biosensor venture founded by proven experts in the continuous glucose monitoring space, announced a $60 million Series A+ financing.

May 22, 2024
·
2 min read
Pharm Country

Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer Patients and Treatment of Inflammatory Diseases with well-known CRO partner

Perseus Therapeutics, a pioneering biopharmaceutical company based in New York City, is proud to announce the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing hair loss in cancer patients and treating a range of inflammatory diseases, including asthma.

May 22, 2024
·
2 min read
Deals

Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

Virios Therapeutics, Inc. today announced the closing of its previously announced public offering of 8,500,000 shares of its common stock at a public offering price of $0.20 per share.

May 22, 2024
·
4 min read
Deals

MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio, Furthering Ambition to Be a Leading Supplier for Viral Vector Manufacturing

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the signing of a definitive agreement to acquire Mirus Bio for US$ 600 million.

May 22, 2024
·
4 min read
Report from the Annual General Meeting 2024 of IRLAB Therapeutics AB

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Today, on Wednesday May 22, 2024, IRLAB Therapeutics AB held its Annual General Meeting.

May 22, 2024
·
7 min read